Two-day training with real-world cases and practical application organized in collaboration with Prescription Pharma Support ...

Rolling submission of Biologics License Agreement (BLA) to U.S. Food and Drug Administration (FDA) seeking ST-920 approval is in progress.Six ...

Antidepressants recalled after wrong tablets found in pack - A strip of Citalopram 40mg tablets was found by a patient inside a packet of Sertraline 100mg tablets ...

CORDStrom supply chain -- A new expanded material transfer agreement with Anthony Nolan U.K. Cord Blood Bank secures long-term umbilical cord supply for commercial manufacturing. XPro development -- ...

On 30 April, techUK convened senior leaders from across the digital health, life sciences, and social care industry in Leeds ...

INmune Bio Inc. (NASDAQ: INMB), a late-stage biotechnology company focused on inflammation and immunology, today announced ...

Q4 2025 Earnings Call April 28, 2026 12:00 PM EDTCompany ParticipantsJeremy Skillington - CEO & DirectorLiam Tremble ...

Greetings, and welcome to the INmune Bio's 2026 First Quarter Earnings Call. As a reminder, this conference is being recorded. A transcript will follow within 24 hours of this conference call. At this ...

Malignant tumours account for approximately 3–7% of flagged results across Autoderm deployments. The platform screens for the three most clinically significant skin cancers: malignant melanoma, basal ...

INmune Bio Inc. (NASDAQ: INMB), a late-stage biotechnology company focused on inflammation and immunology, today announced that the U.S. Food and Drug ...

Sustained LLVA responder rates at 12 months reinforced the earlier 9-month signal and aligned with the endpoints selected for ...